Hyperphenylalaninemia due to tetrahydrobiopterin deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:238583OMIM:264070E70.1
Who is this for?
Show terms as
2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hyperphenylalaninemia due to tetrahydrobiopterin (BH4) deficiency is a rare inherited metabolic disorder that causes high levels of the amino acid phenylalanine in the blood. Unlike classic phenylketonuria (PKU), which is caused by a problem with the enzyme that breaks down phenylalanine, this condition is caused by the body's inability to make or recycle tetrahydrobiopterin — a small molecule that is essential for several important enzymes to work properly. BH4 is needed not only to break down phenylalanine but also to produce key brain chemicals (neurotransmitters) such as dopamine and serotonin. Because of this, the disease affects both metabolism and brain function. Symptoms typically appear in the first months of life and can include developmental delay, movement problems, seizures, difficulty swallowing, and abnormal muscle tone. Without treatment, the condition can lead to severe intellectual disability and progressive neurological decline. Newborn screening programs can detect elevated phenylalanine levels shortly after birth, but additional testing is needed to distinguish BH4 deficiency from classic PKU. Treatment involves supplementing BH4 (sapropterin), replacing the missing neurotransmitter precursors (such as L-DOPA and 5-hydroxytryptophan), and sometimes following a low-phenylalanine diet. Early diagnosis and prompt treatment are critical to achieving the best possible outcomes. With appropriate lifelong therapy, many patients can experience significant improvement, though the degree of benefit depends on the specific type and severity of the deficiency.

Also known as:

Key symptoms:

Developmental delayIntellectual disabilitySeizuresAbnormal muscle tone (too stiff or too floppy)Movement problems such as tremors or involuntary movementsDifficulty swallowingExcessive droolingIrritabilityPoor head controlSleep disturbancesTemperature instabilitySlow growthBehavioral problemsEpisodes of drowsiness or lethargy

Clinical phenotype terms (24)— hover any for plain English
HyperphenylalaninemiaHP:0004923Excessive salivationHP:0003781Decreased CSF homovanillic acid concentrationHP:0003785Abnormal circulating neopterin concentrationHP:0040206Abnormal circulating biopterin concentrationHP:0040210Abnormal urinary nitrogen compound levelHP:0040416Basal ganglia calcificationHP:0002135HypomagnesemiaHP:0002917Maturity-onset diabetes of the youngHP:0004904
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hyperphenylalaninemia due to tetrahydrobiopterin deficiency.

View clinical trials →

No actively recruiting trials found for Hyperphenylalaninemia due to tetrahydrobiopterin deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hyperphenylalaninemia due to tetrahydrobiopterin deficiency community →

Specialists

2 foundView all specialists →
AP
Anita MacDonald, Professor
Specialist
PI on 2 active trials1 Hyperphenylalaninemia due to tetrahydrobiopterin deficiency publication
EM
Ece Kucuksayrac, MD
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hyperphenylalaninemia due to tetrahydrobiopterin deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hyperphenylalaninemia due to tetrahydrobiopterin deficiencyForum →

No community posts yet. Be the first to share your experience with Hyperphenylalaninemia due to tetrahydrobiopterin deficiency.

Start the conversation →

Latest news about Hyperphenylalaninemia due to tetrahydrobiopterin deficiency

No recent news articles for Hyperphenylalaninemia due to tetrahydrobiopterin deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific type of BH4 deficiency does my child have, and which gene is affected?,What medications will my child need, and how often do doses need to be adjusted?,How will we monitor whether the treatment is working well enough?,Does my child need a special diet, and if so, how strict does it need to be?,What developmental outcomes can we realistically expect with treatment?,Are there any clinical trials or new therapies being studied for this condition?,What should I do if my child has a seizure or a sudden change in behavior or movement?

Common questions about Hyperphenylalaninemia due to tetrahydrobiopterin deficiency

What is Hyperphenylalaninemia due to tetrahydrobiopterin deficiency?

Hyperphenylalaninemia due to tetrahydrobiopterin (BH4) deficiency is a rare inherited metabolic disorder that causes high levels of the amino acid phenylalanine in the blood. Unlike classic phenylketonuria (PKU), which is caused by a problem with the enzyme that breaks down phenylalanine, this condition is caused by the body's inability to make or recycle tetrahydrobiopterin — a small molecule that is essential for several important enzymes to work properly. BH4 is needed not only to break down phenylalanine but also to produce key brain chemicals (neurotransmitters) such as dopamine and serot

How is Hyperphenylalaninemia due to tetrahydrobiopterin deficiency inherited?

Hyperphenylalaninemia due to tetrahydrobiopterin deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hyperphenylalaninemia due to tetrahydrobiopterin deficiency typically begin?

Typical onset of Hyperphenylalaninemia due to tetrahydrobiopterin deficiency is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Hyperphenylalaninemia due to tetrahydrobiopterin deficiency?

2 specialists and care centers treating Hyperphenylalaninemia due to tetrahydrobiopterin deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.